BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16953223)

  • 1. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
    Oeggerli M; Schraml P; Ruiz C; Bloch M; Novotny H; Mirlacher M; Sauter G; Simon R
    Oncogene; 2006 Oct; 25(49):6538-43. PubMed ID: 16953223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer].
    Oeggerli M; Schraml P; Novotny H; Sauter G; Simon R
    Verh Dtsch Ges Pathol; 2005; 89():219-24. PubMed ID: 18035695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
    Oeggerli M; Tomovska S; Schraml P; Calvano-Forte D; Schafroth S; Simon R; Gasser T; Mihatsch MJ; Sauter G
    Oncogene; 2004 Jul; 23(33):5616-23. PubMed ID: 15122326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification and overexpression of E2F3 in human bladder cancer.
    Feber A; Clark J; Goodwin G; Dodson AR; Smith PH; Fletcher A; Edwards S; Flohr P; Falconer A; Roe T; Kovacs G; Dennis N; Fisher C; Wooster R; Huddart R; Foster CS; Cooper CS
    Oncogene; 2004 Feb; 23(8):1627-30. PubMed ID: 14716298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.
    Wu Q; Hoffmann MJ; Hartmann FH; Schulz WA
    Mol Cancer; 2005 May; 4(1):16. PubMed ID: 15876350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
    Hurst CD; Tomlinson DC; Williams SV; Platt FM; Knowles MA
    Oncogene; 2008 Apr; 27(19):2716-27. PubMed ID: 18037967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer.
    Ruiz C; Holz DR; Oeggerli M; Schneider S; Gonzales IM; Kiefer JM; Zellweger T; Bachmann A; Koivisto PA; Helin HJ; Mousses S; Barrett MT; Azorsa DO; Bubendorf L
    J Pathol; 2011 Mar; 223(4):543-52. PubMed ID: 21294127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line.
    Kawasaki T; Yokoi S; Tsuda H; Izumi H; Kozaki K; Aida S; Ozeki Y; Yoshizawa Y; Imoto I; Inazawa J
    Cancer Sci; 2007 Jul; 98(7):1070-7. PubMed ID: 17459056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.
    Kuuselo R; Savinainen K; Azorsa DO; Basu GD; Karhu R; Tuzmen S; Mousses S; Kallioniemi A
    Cancer Res; 2007 Mar; 67(5):1943-9. PubMed ID: 17332321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
    Zheng M; Simon R; Mirlacher M; Maurer R; Gasser T; Forster T; Diener PA; Mihatsch MJ; Sauter G; Schraml P
    Am J Pathol; 2004 Jul; 165(1):63-9. PubMed ID: 15215162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis of 6p22 genomic gain in retinoblastoma.
    Orlic M; Spencer CE; Wang L; Gallie BL
    Genes Chromosomes Cancer; 2006 Jan; 45(1):72-82. PubMed ID: 16180235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear overexpression of the E2F3 transcription factor in human lung cancer.
    Cooper CS; Nicholson AG; Foster C; Dodson A; Edwards S; Fletcher A; Roe T; Clark J; Joshi A; Norman A; Feber A; Lin D; Gao Y; Shipley J; Cheng SJ
    Lung Cancer; 2006 Nov; 54(2):155-62. PubMed ID: 16938365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.
    Medina PP; Castillo SD; Blanco S; Sanz-Garcia M; Largo C; Alvarez S; Yokota J; Gonzalez-Neira A; Benitez J; Clevers HC; Cigudosa JC; Lazo PA; Sanchez-Cespedes M
    Hum Mol Genet; 2009 Apr; 18(7):1343-52. PubMed ID: 19153074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.
    Laurila E; Savinainen K; Kuuselo R; Karhu R; Kallioniemi A
    Genes Chromosomes Cancer; 2009 Apr; 48(4):330-9. PubMed ID: 19145645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer.
    Shen H; Morrison CD; Zhang J; Underwood W; Yang N; Frangou C; Eng K; Head K; Bollag RJ; Kavuri SK; Rojiani AM; Li Y; Yan L; Hill A; Woloszynska-Read A; Wang J; Liu S; Trump DL; Candace JS
    Oncotarget; 2013 Nov; 4(11):2124-34. PubMed ID: 24231253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells.
    Olsson AY; Feber A; Edwards S; Te Poele R; Giddings I; Merson S; Cooper CS
    Oncogene; 2007 Feb; 26(7):1028-37. PubMed ID: 16909110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.
    Begum A; Imoto I; Kozaki K; Tsuda H; Suzuki E; Amagasa T; Inazawa J
    Cancer Sci; 2009 Oct; 100(10):1908-16. PubMed ID: 19594544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma.
    Grasemann C; Gratias S; Stephan H; Schüler A; Schramm A; Klein-Hitpass L; Rieder H; Schneider S; Kappes F; Eggert A; Lohmann DR
    Oncogene; 2005 Sep; 24(42):6441-9. PubMed ID: 16007192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes.
    Kao J; Pollack JR
    Genes Chromosomes Cancer; 2006 Aug; 45(8):761-9. PubMed ID: 16708353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.